SLTM  Solta Medical Inc




Health Care


Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.


Vuru Grade


Current Price

+0.00 (+0.00%)

Growth Price

Overvalued by 36.24%

Stability Price

Fairly valued

Company Metrics

  • P/E 162.22
  • P/S 1.56
  • P/B 1.71
  • EPS 0.02
  • Cash ROIC -0.79%
  • Cash Ratio 0.65
  • Dividend 0 / 0%
  • Avg. Vol. 1.50M
  • Shares 64.44M
  • Market Cap. 235.8M

Company Description

Solta Medical, Inc. designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications. Its products include Thermage NXT and CPT systems that provide non-invasive treatment options for skin tightening and contouring, body shaping, and enhancement in the appearance of cellulite; Fraxel re:fine and Fraxel re:store systems, which offer treatments for skin con... more

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in ...
PR Newswire (press release) - Dec 16, 2013
16, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Solta Medical, Inc.
Valeant to acquire Solta Medical for $236 million - Reuters
Valeant Acquires Solta Medical -
Solta Medical Supports LGBTQ Community And The Zebra Coalition (press release) - Oct 19, 2016
Solta Medical, Inc., wholly owned subsidiary of Valeant Pharmaceuticals International, Inc., is a global leader in providing innovative and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians.
Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.
PR Newswire (press release) - May 24, 2013
HAYWARD, Calif., May 24, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today reported Dr.
Solta Medical explores sale after loss exceeds estimate
Reuters - Nov 12, 2013
Solta Medical Inc SLTM.O is exploring a sale due to falling profits from its medical equipment to remove fat and improve the appearance of a person's skin and pressure from activist investor Voce Capital Management LLC.
Solta Medical Reports Third Quarter 2013 Results and Actions Implemented to ... - PR Newswire (press release)
Solta Medical to Acquire Sound Surgical Technologies
PR Newswire (press release) - Jan 29, 2013
29, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Sound Surgical Technologies LLC.
Solta Medical to buy Sound Surgical Technologies for $30.5 million - San Francisco Business Times (blog)
Solta Medical Announces Thermage CPT™ and Fraxel re:store® Dual Systems ...
PR Newswire (press release) - Jun 28, 2010
HAYWARD, Calif., June 28 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced Health Canada approval of ...
Solta Medical CEO steps down as company revamps sales strategy
San Francisco Business Times (blog) - Aug 6, 2013
Solta Medical Inc.'s top executive is leaving - with two years' salary and a consulting deal - after a disappointing second quarter and as the acquisitive cosmetic medical devices developer adjusts its sales strategy.
Solta Medical Seeks Deals in Downturn
Wall Street Journal - Jan 12, 2009
The sagging economy hasn't spared makers of aesthetic medical equipment -- used in everything from facial rejuvenation to acne treatments -- but the chief executive of Solta Medical Inc. sees it as an opportunity to do more deals. Solta, formerly ...
Solta Medical Launches Clear + Brilliant pelo™: A New and Innovative Linear ...
PR Newswire (press release) - Sep 10, 2015
10, 2015 /PRNewswire/ -- Solta Medical, a division of Valeant Pharmaceuticals North America LLC today announced the availability of the Clear + Brilliant pelo™ laser in the United States, a sophisticated approach to permanent hair reduction.
Solta Medical Agrees To Be Acquired By Valeant, But Another Bid Might Emerge
Seeking Alpha - Dec 23, 2013
On Monday, December 16th, Valeant (NYSE:VRX) submitted what for the time being, is the winning bid to acquire Solta Medical Devices (NASDAQ:SLTM). For some time now, we have been predicting that Solta would be acquired before the end of this year.